on 14 Sep 2021
Last Applicant/ Owned by
Industrielaan 63 NL-5349 AE Oss
NL
Serial Number
79293817 filed on 21st Jul 2020
Registration Number
6481068 registered on 14th Sep 2021
Correspondent Address
Bryce J. Maynard
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis; antibodies for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis; antibodies for the prRead More
Pharmaceutical preparations for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis; antibodies for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis; antibodies for the prevention or treatment of autoimmune diseases; small molecules, gene therapies and peptides for the prevention or treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis
No 79293817
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 21st Mar 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 02th Mar 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| 01st Mar 2022 | FINAL DISPOSITION PROCESSED |
| 14th Dec 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 04th Dec 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 14th Sep 2021 | REGISTERED-PRINCIPAL REGISTER |
| 29th Jun 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 29th Jun 2021 | PUBLISHED FOR OPPOSITION |
| 09th Jun 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 27th May 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
